Skip to content

Septerna, Inc. SEPN Change in Lease Liabilities

Change in Lease Liabilities at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$205K+112%
Precigen logo
PrecigenPGEN
-$75K+21.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$106K-9.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$802K+20.9%
Arrowhead Research logo
Arrowhead ResearchARWR
-$1.21M-7.5%
Enliven Therapeutics logo
Enliven TherapeuticsELVN
-$97K-40.6%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s change in lease liabilities?
Septerna, Inc. (SEPN) reported change in lease liabilities of -$535K in Q1 2026.
How has Septerna, Inc.'s change in lease liabilities changed year-over-year?
Septerna, Inc.'s change in lease liabilities decreased by 18.9% year-over-year, from -$450K to -$535K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.